185 related articles for article (PubMed ID: 17130457)
1. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.
Nakayama K; Nakayama N; Davidson B; Sheu JJ; Jinawath N; Santillan A; Salani R; Bristow RE; Morin PJ; Kurman RJ; Wang TL; Shih IeM
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18739-44. PubMed ID: 17130457
[TBL] [Abstract][Full Text] [Related]
2. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.
Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Fukumoto M; Miyazaki K
Clin Cancer Res; 2008 May; 14(10):3149-55. PubMed ID: 18483383
[TBL] [Abstract][Full Text] [Related]
3. NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor.
Nakayama K; Nakayama N; Wang TL; Shih IeM
Cancer Res; 2007 Sep; 67(17):8058-64. PubMed ID: 17804717
[TBL] [Abstract][Full Text] [Related]
4. Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.
Yeasmin S; Nakayama K; Ishibashi M; Katagiri A; Iida K; Purwana IN; Nakayama N; Miyazaki K
Clin Cancer Res; 2008 Mar; 14(6):1686-91. PubMed ID: 18347169
[TBL] [Abstract][Full Text] [Related]
5. NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.
Jinawath N; Vasoontara C; Yap KL; Thiaville MM; Nakayama K; Wang TL; Shih IM
Oncogene; 2009 May; 28(18):1941-8. PubMed ID: 19305429
[TBL] [Abstract][Full Text] [Related]
6. NAC1, a cocaine-regulated POZ/BTB protein interacts with CoREST.
Korutla L; Degnan R; Wang P; Mackler SA
J Neurochem; 2007 May; 101(3):611-8. PubMed ID: 17254023
[TBL] [Abstract][Full Text] [Related]
7. NAC1, a POZ/BTB protein that functions as a corepressor.
Korutla L; Wang P; Jackson TG; Mackler SA
Neurochem Int; 2009; 54(3-4):245-52. PubMed ID: 19121354
[TBL] [Abstract][Full Text] [Related]
8. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat.
Mackler SA; Korutla L; Cha XY; Koebbe MJ; Fournier KM; Bowers MS; Kalivas PW
J Neurosci; 2000 Aug; 20(16):6210-7. PubMed ID: 10934270
[TBL] [Abstract][Full Text] [Related]
9. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
10. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
11. Nac1 interacts with the POZ-domain transcription factor, Miz1.
Stead MA; Wright SC
Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24702277
[TBL] [Abstract][Full Text] [Related]
12. The BTB/POZ domain of the regulatory proteins Bric à brac 1 (BAB1) and Bric à brac 2 (BAB2) interacts with the novel Drosophila TAF(II) factor BIP2/dTAF(II)155.
Pointud JC; Larsson J; Dastugue B; Couderc JL
Dev Biol; 2001 Sep; 237(2):368-80. PubMed ID: 11543621
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of a novel human BTBD8 gene containing double BTB/POZ domains.
Xu J; He T; Wang L; Wu Q; Zhao E; Wu M; Dou T; Ji C; Gu S; Yin K; Xie Y; Mao Y
Int J Mol Med; 2004 Jan; 13(1):193-7. PubMed ID: 14654994
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6.
Zhang W; Mi J; Li N; Sui L; Wan T; Zhang J; Chen T; Cao X
Biochem Biophys Res Commun; 2001 Apr; 282(4):1067-73. PubMed ID: 11352661
[TBL] [Abstract][Full Text] [Related]
15. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain.
Kobayashi A; Yamagiwa H; Hoshino H; Muto A; Sato K; Morita M; Hayashi N; Yamamoto M; Igarashi K
Mol Cell Biol; 2000 Mar; 20(5):1733-46. PubMed ID: 10669750
[TBL] [Abstract][Full Text] [Related]
16. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
17. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
[TBL] [Abstract][Full Text] [Related]
18. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
19. BTB/POZ domain of speckle-type POZ protein (SPOP) confers proapoptotic function in HeLa cells.
Byun B; Tak H; Joe CO
Biofactors; 2007; 31(3-4):165-9. PubMed ID: 18997279
[TBL] [Abstract][Full Text] [Related]
20. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.
Li X; Peng H; Schultz DC; Lopez-Guisa JM; Rauscher FJ; Marmorstein R
Cancer Res; 1999 Oct; 59(20):5275-82. PubMed ID: 10537309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
